Trial Profile
Planned clinical trial of valomaciclovir for multiple sclerosis
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2012
Price :
$35
*
At a glance
- Drugs Valomaciclovir (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Epiphany Biosciences
- 08 Apr 2009 New trial record.